We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis

By LabMedica International staff writers
Posted on 03 Mar 2025
Print article
Image: The squares are representative partial pictures from the cancer microscopy slides, that the AI system has automatically organized by their similarity (Photo courtesy of University of Jyväskylä)
Image: The squares are representative partial pictures from the cancer microscopy slides, that the AI system has automatically organized by their similarity (Photo courtesy of University of Jyväskylä)

Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present. A new artificial intelligence (AI)-driven tool has now been developed to identify colorectal cancer in tissue samples that surpasses all previous models in terms of classification accuracy.

This tool was the result of a collaborative study led by researchers at the University of Jyväskylä (Jyväskylä, Finland). The AI model created in this study demonstrated superior performance in classifying tissue samples compared to prior models. This new tool has the potential to streamline the process for doctors by automating the analysis of tissue slides. It analyzes samples and highlights areas with various tissue types, offering a level of accuracy that could greatly reduce the workload of histopathologists, leading to faster diagnoses, prognoses, and clinical insights.

The research team has made this AI tool publicly available to promote further research and collaboration. While the results are promising, the team emphasizes that the integration of AI tools into clinical practice should be approached cautiously. For AI solutions to become standard in clinical settings, they must undergo a thorough validation process to ensure that they meet both clinical and regulatory standards.

"Based on our study, the developed model is able to identify all tissue categories relevant for cancer identification, with an accuracy of 96.74%," said Fabi Prezja, the researcher responsible for designing the method. "The free availability aims to accelerate future advances by encouraging scientists, developers and researchers worldwide to continue developing the tool and finding new applications for it."

Related Links:
University of Jyväskylä

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Dehydroepiandrosterone Assay
DHEA ELISA
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073

Print article

Channels

Immunology

view channel
Image: New research has revealed a novel biomarker for autoimmune diseases (Photo courtesy of Shutterstock)

Novel Analytical Method Tracks Progression of Autoimmune Diseases

Patients with autoimmune diseases often have lifelong contact with doctors and hospitals. The typical patient diagnosed is a woman in her fifties and the disease requires lifelong treatment.... Read more

Microbiology

view channel
Image: The unique barcoding system enables tracking of K. pneumoniae as it moves throughout the body (Photo courtesy of AdobeStock)

Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream

Bacteremia, also known as blood poisoning, occurs when bacteria manage to overcome the body's immune defenses. This condition can progress into sepsis, a serious illness that is responsible for over a... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.